To appraise the clinical and cost effectiveness of dexamethasone intracanalicular insert within its marketing authorisation for treating inflammation and pain after cataract surgery.
- Status:
- Awaiting development
- Technology type:
- Medicine
- Decision:
- None selected
- Process:
- STA Standard
- ID number:
- 1154
Project Team
- Project lead
- Michelle Adhemar
Email enquiries
If you have any queries please email [email protected]
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 11 September 2017 (00:00) | Scoping workshop |
| 18 July 2017 - 15 August 2017 | Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators |
For further information on our processes and methods, please see our CHTE processes and methods manual